Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer
Interventions: DRUG: telapristone acetate|OTHER: placebo|PROCEDURE: therapeutic conventional surgery|OTHER: laboratory biomarker analysis|OTHER: questionnaire administration
Sponsor: Northwestern University
Collaborators: Breast Cancer Research Foundation|Repros Therapeutics Inc.